Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours Β· Estimated delivery Oct 8 - Oct 13
IBS is a chronic functional gastrointestinal disorder characterised by recurrent abdominal pain associated with altered bowel habits, typically diagnosed using the Rome IV criteria (symptom onset at least 6 months before diagnosis, with abdominal pain at least 1 day/week in the last 3 months, plus related stool/defecation criteria)
Chronic inflammation is linked to various health issues, including heart disease, diabetes, and certain cancers
The peptide acts as a signalling molecule that communicates with cells, telling them to repair, regenerate, and produce essential proteins
The synergy works at two levels
Company announcement: Novo Nordisk A/S: Wegovy pill approved in the US as first oral GLP-1 for weight management
US$ 27.42
US$ 22.39
US$ 26.93
US$ 29.34
US$ 24.43
US$ 26.48
